NCT05828875尚未招募不适用
A Multicenter, Cross-sectional Study on the Quality of Life in Long-term Survival Esophageal Cancer Patients After Radical Radiochemotherapy/Radiotherapy
Tianjin Medical University Cancer Institute and Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2023年8月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Quality of Life Assessment survey
研究概览
简要总结
This study is a multicenter cross-sectional survey of esophageal cancer patients who underwent radical chemoradiotherapy/radiotherapy from July 2017 to July 2020 in various medical centers, and who survived without disease progression at the time of the survey. The purpose of this study is to evaluate the current quality of life, as well as the incidence of long-term toxic side effects, nutritional status, and psychological status of esophageal cancer patients cured by radiotherapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Voluntarily accept this survey and research;
- •The age at the time of radiotherapy is between 18-75 years old, and the age at the time of investigation is<80 years old;
- •Histologically confirmed esophageal squamous cell carcinoma without undergoing surgical resection;
- •Received radical chemoradiotherapy/radiotherapy from July 2017 to July 2020, currently alive and without disease progression;
- •Radiotherapy dose ≥ 45Gy.
排除标准
- •Patients who do not cooperate with this survey;
- •Patients who have died at the time of investigation;
- •Patients who experience tumor progression within the time frame from the end of radiotherapy to receiving this survey;
- •Patients diagnosed with other malignant tumors within the time frame from the end of radiotherapy to receiving this survey;
- •Patients with incorrect contact information and missing visits
结局指标
主要结局
Quality of Life Assessment survey
时间窗: Two years after the end of radiotherapy
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
终止
不适用
Esophagectomy With or Without Prior Ischemic Gastric PreconditioningEsophageal CancerNCT02457299NorthShore University HealthSystem1
招募中
2 期
Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCCEsophageal Cancer by AJCC V8 StageNCT05738434The First Affiliated Hospital of Zhengzhou University188
招募中
不适用
Surgically Treated Displaced Mid-diaphyseal Clavicle FracturesClavicle FractureNCT05867355University of Calgary111
招募中
不适用
TREAT-BE Study (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)Barrett's EsophagusEsophageal CancerNCT02634645University of Colorado, Denver5,000
招募中
不适用
PRIMA EU Retrospective & ProspectiveArthroplastyReplacementShoulderNCT06371833Limacorporate S.p.a60